This forum is for questions about medical issues and research aspects of Hepatitis such as, questions about being newly diagnosed, questions about current treatments, information and participation in discussions about research studies and clinical trials related to Hepatitis. If you have a medical question, comment or research study pertaining to Hepatitis, please post it in our
Hepatitis Forum
Two forms of peginterferon have been developed and studied in large clinical trials: peginterferon alfa-2a (Pegasys: Hoffman La Roche, Nutley, NJ) and peginterferon alfa-2b (Pegintron: Schering-Plough Corporation, Kenilworth, NJ). These two products are roughly equivalent in efficacy and safety, but have different dosing regimens.
Peginterferon alfa-2a is given subcutaneously in a fixed dose of 180 micrograms (mcg) per week.
Peginterferon alfa-2b is given subcutaneously weekly in a weight-based dose of 1.5 mcg per kilogram (kg) per week (thus in the range of 75 to 150 mcg per week).
Ribavirin is an oral medication, given twice a day in 200-mg capsules for a total daily dose based upon body weight. The standard dose of ribavirin is 1,000 mg for patients who weigh less than 75 kg (165 pounds) and 1,200 mg for those who weigh more than 75 kg. In certain situations, an 800-mg dose (400 mg twice daily) is recommended (see Duration).
I'll pass on Mel Gibson.... Sorry about that
http://www.youtube.com/watch?v=76i6aZgo2io
a feel good song
jasper
4 CUPS WATER
1 ORGANIC BULLION CUBE
1/2 CUP PASTA
DONE DEAL